Prospective Randomized Group Controlled Trial (RCT) of Clinical Efficacy and Safety of the IntegrAire Supraglottic Airway Device

Prospective Randomized Group Controlled Trial (RCT) of Clinical Efficacy and Safety of the IntegrAire Supraglottic Airway Device - SAD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00028132

Enrollment

118

Registered

2024-04-17

Start date

2024-01-10

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilation during anesthesia

Interventions

Group 1: IntegrAire Supraglottic Airway Device Group 2: Conventionel laryngeal mask

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Need for anesthesia

Exclusion criteria

Exclusion criteria: Head reclination

Design outcomes

Primary

Measure	Time frame
CO2 return	—

Secondary

Measure	Time frame
Insertion quality	—

Countries

Germany

Contacts

Public ContactGregor Massoth

Universitätsklinikum Bonn

gregor.massoth@ukbonn.de0049 228 287 15074

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026